Viking Therapeutics, Inc. (VKTX)

NCM – Цена в реальном времени. Валюта: USD

34.34

+0.54 (1.60%)

Рынок открыт: Aug 12, 2026, 1:14 PM EDT

33.86

+0.06 (0.18%)

Предыдущая сессия: Aug 11, 2026, 7:59 PM EDT

08.08.2026

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Eli Lilly leads the GLP-1 market and could remain on top thanks to a deep pipeline. Viking Therapeutics' leading GLP-1 candidate looks very promising.

07.08.2026

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics (VKTX) maintains a Hold rating as competitive pressures intensify in the GLP-1 obesity drug space and key data catalysts approach. VKTX's lead asset VK2735 is in large Phase 3 VANQUISH trials, but efficacy expectations are high, and prior data is limited to a small, short Phase 2 study. A pivotal Q3 catalyst is the maintenance dosing study for VK2735; results could drive price volatility and influence funding needs amid high cash burn.

06.08.2026

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Cash burn and potential dilution are key investor concerns. The company's phase 3 trials remain on track, and investors are awaiting results from a maintenance trial this quarter.

Видео

No Data

There is no data to display

Viking Therapeutics, Inc. (VKTX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Viking Therapeutics, Inc. (VKTX)

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Видео

No Data

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Видео

No Data

Search stocks

Viking Therapeutics, Inc. (VKTX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Viking Therapeutics, Inc. (VKTX)

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Видео

No Data

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Видео

No Data